Clinical Trial Update: A Long-term Follow-up Study for Cardiac Safety in the Patients With HER2 (+) Breast Cancer Who Have Completed the SB3-G31-BC

View source ↗

Summary

A long-term follow-up study assessing cardiac safety in HER2-positive breast cancer patients who completed SB3-G31-BC; study status terminated with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Breast Neoplasms

Drugs mentioned

• SB3-G31-BC

Snippet

Sponsor: Samsung Bioepis Co., Ltd. | Conditions: Breast Neoplasms | Status: TERMINATED | Results posted: 2024-02-02